An ongoing dialogue on HIV/AIDS, infectious diseases,
September 8th, 2019
The Curious Case of M184V, Part 2 — and More!
The inspiration for today’s post comes from two recent emails from ID/HIV colleagues — thank you. Here’s the first, from Dr. Mehri McKellar from Duke: Hi Paul, When are you going to do part 2 of The Curious Case of M184V, Part 1? I am waiting patiently. 🙂 Mehri Mehri, wait no more, because here it is! […]
May 21st, 2017
The Curious Case of M184V, Part 1
Thanks to our sophisticated research team here at NEJM Journal Watch, we have an excellent idea who reads this thing for its scintillating ID/HIV content. Most of you are clinicians — doctors, nurses, PAs, PharmDs. A smaller proportion are researchers, lab-oriented types who wandered over here unexpectedly after an errant search, expecting the latest in CRISPR-Cas9 gene editing and […]
November 16th, 2013
Janssen to Stop Offering “Virtual Phenotype” Testing, and Musings on Progress
Head over to this page from Janssen Diagnostics, and you’ll receive this little pop-up message: Must say it’s in some ways sad to see it go — in my opinion the nifty work they did correlating genotype results with their database of phenotypes gave the clearest representation of what a genotype actually means. If you didn’t […]